Most articles about life settlement pricing focus on what the seller receives — broker commissions, gross payout versus net proceeds, marketplace competition between providers. These topics matter for policyholders selling unwanted coverage, but they answer the wrong question for an accredited investor evaluating direct-ownership opportunities. The investor needs to understand the buy-side pricing math: how the institutional purchaser calculates the maximum price they can pay while still hitting their target IRR. After more than two decades executing this math on hundreds of transactions, the framework below is how I evaluate every opportunity that reaches the investor desk.

The NPV foundation — pricing as backward IRR math

Life settlement pricing operates on a single core principle: the maximum price a buyer can pay equals the net present value of all expected future cash flows discounted at the buyer's required rate of return. Unlike public market pricing — where bid and ask emerge from continuous order flow and observable liquidity — life settlement pricing must be constructed from policy-specific inputs because each policy is unique and there is no real-time price feed.

Three inputs drive the entire calculation. First, the projected death benefit at maturity — typically the policy's face value, sometimes adjusted for known riders, lapses of optional benefits, or policy-specific provisions affecting the ultimate payout. For most institutional life settlement transactions, this is a known quantity from the policy contract.

Second, the life expectancy estimate — provided by independent underwriting firms such as 21st Services, ISC, Fasano, or Predictive Resources. The LE estimate determines when the death benefit is expected to be received, and therefore how much premium must be paid in the interim. A shorter LE means earlier maturity and less premium drag; a longer LE means more premium payments and a lower purchase price for the same target IRR.

Third, the premium schedule — the annual or monthly premium obligations the buyer must fund to keep the policy in force through maturity. Premium loads vary substantially by policy type (universal life, whole life, term conversion), the insured's age and health, and the policy's existing cost-of-insurance schedule. Premium projections are critical inputs to pricing because they directly reduce NPV.

With these three inputs, the investor calculates the NPV of all expected cash flows: minus annual premiums for years 1 through LE-months/12, plus death benefit at month LE. The discount rate is the buyer's target IRR — typically 12-16% for institutional direct-ownership investors in this asset class, reflecting the illiquidity premium, longevity uncertainty, and structural risk of the asset. The NPV at this discount rate equals the maximum purchase price the buyer can pay.

A $500K policy worked example — six steps to the bid

The cleanest way to see this math operate is to walk through a specific transaction. The example below uses parameters representative of a typical institutional life settlement evaluation: $500,000 face value, 60-month LE estimate, $30,000 annual premium load, 14% target IRR. Each step is a concrete calculation; the final result is the maximum bid the institutional buyer can offer.

Several observations about this math deserve emphasis. The maximum bid is highly sensitive to the LE estimate. If the LE were 48 months instead of 60 (a 12-month shortening), holding all other inputs constant, the maximum bid would rise to approximately $190,000 — a 21% increase. Conversely, an LE estimate of 72 months would compress the bid to approximately $128,000 — a 18% reduction. This is why independent LE underwriting matters so much: every month of LE shift moves the bid materially.

The bid is also sensitive to the target IRR. At a 12% target IRR instead of 14%, the same policy supports a bid of approximately $172,000 — a 10% increase. At 16% target IRR, the bid compresses to approximately $143,000. Different institutional buyers operate at different target IRRs based on their cost of capital, liquidity constraints, and portfolio strategy; this variance creates competitive bidding dynamics in the broker auction process.

Premium load matters more than many investors initially appreciate. If annual premiums were $40,000 instead of $30,000, the maximum bid would compress to approximately $123,000 — a 22% reduction for a 33% increase in premium load. Premium projections that prove to be aggressive after closing can erode realized IRR substantially.

The bid stack — from initial bid to net seller proceeds

The buyer's NPV-calculated maximum bid is rarely the final transaction price. Multiple parties touch the transaction between the buyer's institutional desk and the seller's net check, and each party affects the pricing chain. Understanding the bid stack is essential for accredited investors to evaluate whether a presented opportunity reflects efficient pricing or carries embedded inefficiencies.

The transaction looks different from each party's perspective. The institutional buyer pays $168,000 for an expected $500,000 death benefit at month 60, with $150,000 in cumulative premiums over the holding period — producing the target IRR. The broker earns $30,000 on the transaction (6% of face value, a common commission structure). The seller receives $138,000 net — substantially more than the policy's cash surrender value, which might be $30,000-$50,000 on the same policy.

For accredited investors evaluating a direct-ownership opportunity sourced through a licensed provider partner, the transparent presentation of the bid stack reveals where pricing efficiency exists or where embedded costs erode returns. Institutional platforms that present opportunities with clear chain-of-pricing documentation give the buy-side investor the information needed to confirm their target IRR will be achieved.

Why bid-ask spread exists structurally

The gap between what a buyer is willing to pay and what a seller is willing to accept — the bid-ask spread — is a normal feature of every market, but it exists for specific structural reasons in life settlements that accredited investors should understand.

Origination cost. The provider invests substantial resources before knowing whether a transaction will close: LE underwriting from independent firms ($800-$1,500 per case), legal review of policy documentation, state regulatory compliance documentation, broker commission obligations, and Attending Physician Statement procurement. These costs must be amortized across closed transactions, embedded into the pricing.

Escrow and operational holds. State regulations in most jurisdictions require certain holdback periods on settlement proceeds — typically 7-21 days post-closing during which the seller retains rescission rights. The provider's capital is committed but not earning during this window, requiring compensation through pricing.

Premium reserve and contingency. The buyer typically budgets for premium projections plus a reserve for premium increases over time. If carrier cost-of-insurance schedules change during the holding period, premium loads can rise above projection. The institutional buyer prices in a margin to absorb modest premium overruns without compressing IRR.

Capital deployment timing. Institutional buyers operate within pacing constraints based on portfolio strategy. A buyer with substantial dry powder may bid more aggressively than one whose portfolio is nearing target allocation; this variance creates structural dispersion in offered prices.

Information asymmetry. The provider sees many policies; the seller sees only their own policy. The provider's pricing reflects information advantage from observing market clearing prices across hundreds of transactions; the seller can only verify pricing efficiency by engaging multiple providers competitively. The accredited investors who invest in life settlement policies through HYV see the bid-ask resolution from the institutional buy-side rather than from the policyholder seller-side — which is the structural perspective the secondary market is built around.

The natural consequence of these factors is that the bid-ask spread on individual life settlement transactions typically operates in the 3-7% range of face value, with broker auction processes narrowing the spread on competitive transactions. Accredited investors evaluating direct-ownership opportunities should expect to see this spread reflected in any institutional offering — and should be skeptical of presentations that claim spread elimination through retail-direct or platform-mediated structures, which often re-introduce friction in other forms. For the broader market structure context, see our life settlement market size analysis.

• Pricing operates on backward NPV math. The institutional buyer projects cash flows (death benefit minus premiums), discounts at target IRR (12-16% typical), and back-calculates the maximum bid.
• LE estimate is the most sensitive input. Each month of LE shift moves the maximum bid by approximately $15K on a $500K face value policy at 14% target IRR. Independent LE underwriting from recognized firms is essential.
• Premium load directly compresses pricing. A 33% increase in annual premium load compresses the maximum bid by approximately 22% — premium projection accuracy matters operationally.
• Bid-ask spread is structural, not eliminable. Origination costs, escrow holds, premium reserves, and information asymmetry produce a typical 3-7% spread of face value on competitive transactions.
• Net seller proceeds reflect the transaction stack. After broker commission (typically 6% of face value) and provider acquisition costs, the seller's net check is materially less than the gross transaction price but materially more than cash surrender value.

Frequently asked questions

Disclaimer — This content is for educational and informational purposes only and does not constitute financial, legal, tax, or investment advice. Pricing methodology, target IRR ranges (12-16%), bid-ask spread ranges (3-7% of face value), broker commission structures (6% face value, 20-30% gross price variations), LE sensitivity figures (~$15K per month on $500K face at 14% IRR), premium load impact (33% increase compresses bid by ~22%), and worked example calculations reflect general institutional life settlement market practice and HYV operational experience as of the publication date. The $500K worked example uses representative assumptions; actual transactions vary materially by specific policy characteristics, market conditions, LE underwriting variance among firms, premium projections, regulatory environment, and operational factors. NPV calculations are simplified for illustration; institutional pricing models incorporate additional refinements including stochastic mortality distributions, cost-of-insurance schedule modeling, premium optimization scenarios, and tax treatment integration. LE estimate sensitivity figures assume linear approximation around the base case; actual pricing curves are non-linear, with sensitivity rising in policies near the cusp of common LE thresholds. Realized IRR may differ materially from target IRR due to longevity outcome variance, premium schedule changes, carrier credit events, regulatory changes, and operational factors during the holding period. The 4 major LE underwriters referenced (21st Services, ISC, Fasano, Predictive Resources) operate independently and may produce divergent LE estimates on the same case. Broker commission structures vary across the industry; specific commission terms are negotiated per transaction. Life settlement investments are illiquid, long-duration alternative assets and are generally available only to accredited investors as defined under SEC Rule 501 of Regulation D. Investments involve substantial risk, including potential loss of capital. High Yield Vault is a life settlement investment platform that originates, researches, and presents direct-ownership investment opportunities to accredited investors. HYV is not a licensed life settlement provider, not a registered investment adviser for portfolio management, and not a life settlement broker; references throughout to specific firms (Apollo Global Management, Berkshire Hathaway, Partner Re, 21st Services, ISC, Fasano, Predictive Resources) and pricing structures are illustrative of industry-standard practice rather than endorsement or business relationship. Always consult qualified legal, tax, and financial advisors familiar with your specific situation before making any allocation decision.